Clinical Trial: Botulinum Toxin Type A Versus Oral Ibuprofen for Bruxism

U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07732751) titled 'Botulinum Toxin Type A Versus Oral Ibuprofen for Bruxism' on July 18.

Brief Summary: This randomized controlled trial evaluated the effectiveness of Botulinum Toxin Type A compared with oral ibuprofen in reducing pain and improving oral health-related quality of life in patients with sleep bruxism and jaw muscle pain. Forty participants diagnosed with sleep bruxism were randomly assigned to receive either Botulinum Toxin Type A injections into the masseter and temporalis muscles or oral ibuprofen therapy. Participants were followed for 20 weeks. The primary outcome was pain intensity measured using the Visual Analogue Scale (VAS). S...